Certain factors that are driving the market growth include increase in the volume of surgeries and sports-related injuries and rising awareness about the medical implications of adhesions.
Trauma during surgery can result in fibrous bands connecting surfaces which are normally separate. Adhesions occur despite the best surgical techniques, and such formation of adhesions after surgery causes high morbidity. An effective adhesion barrier for surgery helps reduce the incidence, extent, and severity of postoperative adhesions. Barriers to prevent adhesion should therefore be applied, owing to their ability to reduce the severity of adhesion formation. The oxidised regenerated cellulose and hyaluronate carboxymethylcellulose can safely reduce clinically relevant consequences of adhesions. Hence, due to such benefits associated with the adhesion barriers, the market is expected to observe a steady growth over the forecast period.
Key Market Trends General/Abdominal Surgery is Expected to Hold Significant Market Share in the Application Segment
Adhesive disease represents a significant cause of morbidity for postoperative patients. Most surgical procedures performed by obstetrician and gynecologists are associated with pelvic adhesions that cause subsequent serious sequelae, including small bowel obstruction, infertility, chronic pelvic pain, and difficulty in postoperative treatment, including complexity during subsequent surgical procedures. Adhesion barriers have proven to reduce adhesion-related complications in abdominal surgery. The use of adhesion barriers in open surgery is cost-effective in preventing adhesion-related problems.
Furthermore, companies expansions and new developments in abdominal barriers expected to boost market growth. For instance, in February 2020, Baxter completed the acquisition of Seprafilm Adhesion Barrier and its assets from Sanofi in a deal worth USD 350 million. Seprafilm is used as an adjunct to reduce the incidence, extent and severity of adhesions in pelvic and abdominal surgeries. Thus the market for general/abdominal Surgery expected to have notable growth rate over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
The increasing rate of surgery in the region has been well-documented. The growth in the United States is driven by technological advancement, elderly patients expecting higher levels of function, and reimbursement models that incentivize complex fusion surgery. Adhesion barriers are also useful in oncology surgeries. As per the American Cancer Society’s estimation, the new cases of lung cancer in the United States for 2018 are likely to be around 234,030, and about 154,050 deaths are expected due to lung cancer. The National Institutes of Health estimated that cancer care costs the United States an overall USD 147.5 billion in 2015, USD 13.4 billion of which is due to lung cancer. Surgeons believe that they can cost-effectively reduce the risk of post-operative complications in patients by using the adhesion barriers and hence, these new advances are expected to propel the growth of the market in North America.
Competitive Landscape The global Adhesion Barrier market is moderately competitive and consists of a few major players. Companies like Anika Therapeutics, Baxter International, Leader Biomedical, Betatech Medical, FzioMed, Innocoll Holdings, Integra LifeSciences Holdings Corporation, Johnson & Johnson, MAST Biosurgery, Sanofi, among others, hold the substantial market share in the Adhesion Barrier market.
Reasons to Purchase this report: - The market estimate (ME) sheet in Excel format - 3 months of analyst support
Our reports have been used by over 10K customers, including:
The South & Central America infertility treatment devices and equipment market is expected to reach US$ 108.35 million by 2027 from US$ 62.69 million in 2019. The market is estimated to grow at a CAGR of 7.2% from 2020-2027. The growth of this market can be attributed to key driving factors such as a high rise in the infertility rate and...
The adhesion barriers market is valued at an estimated USD 529 million in 2020 and is projected to reach USD 769 million by 2025, at a CAGR of 7.8% during the forecast period. The increasing volume of surgeries and sports-related injuries, rising geriatric population, and the increasing awareness about adhesion formation and adhesion-related...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Benign Prostatic Hyperplasia Devices Market Report The global benign prostatic hyperplasia devices market is expected to grow at a CAGR of over 22% during the period 2019–2025. The global benign prostatic hyperplasia (BPH) devices market...
The Asia Pacific pre-lit disposable vaginal speculum market is expected to reach US$ 79.35 million by 2027 from US$ 57.80 million in 2019. The market is estimated to grow at a CAGR of 4.1% from 2020 to 2027. Key factors that are driving the market include high prevalence of cervical cancer and increase in government initiatives for cervical...
The Middle East & Africa pre-lit disposable vaginal speculum market is expected to reach US$ 10.72 million by 2027 from US$ 9.19 million in 2019. The market is estimated to grow at a CAGR of 2.0% from 2020 to 2027. Key factors that are driving the market include high prevalence of cervical cancer and increase in government initiatives for...
Knee Reconstruction - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Knee Reconstruction - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Knee Reconstruction Devices pipeline products with comparative analysis of the products...
Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hip Reconstruction Devices pipeline products with comparative analysis...
Arthroscopy Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Arthroscopy Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Arthroscopy Devices pipeline products with comparative analysis of the products at...
The Asia Pacific infertility treatment devices and equipment market is expected to reach US$ 386.64 million by 2027 from US$ 197.90 million in 2019. The market is estimated to grow at a CAGR of 8.9% from 2020 to 2027. The growth of this market can be attributed to key driving factors such as higher rate of infertility in men and women and...
The Europe infertility treatment devices and equipment market is expected to reach US$ 444.27 million in 2027 from US$ 241.64 million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020-2027. The growth of this market can be attributed to key driving factors such as a high rise in in vitro fertilization techniques and...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.